600750 江中藥業
按盤價 
22.350 +0.170 (+0.766%) | 2024/12 - 人民幣(K¥) | 變動 | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | 2019/12 人民幣(K¥) | ||
| 營業總收入 | 4,435,451 | -2.59% | 3,885,183 | 2,873,974 | 2,441,452 | 2,449,404 | |
| 減：營業總成本 | 3,461,306 | -5.01% | 3,229,885 | 2,339,197 | 1,895,961 | 1,931,089 | |
| 其中:營業成本 | 1,617,993 | -1.22% | 1,384,302 | 1,024,854 | 845,522 | 816,751 | |
| 財務費用 | (75,321) | 23.62% | (27,592) | (22,421) | (13,065) | (16,660) | |
| 資產減值損失 | (16,073) | 65.34% | (112) | (1,380) | (2,301) | (2,616) | |
| 公允價值變動收益 | (8,627) | -76.75% | 57,098 | 53,613 | (10,661) | 13,590 | |
| 投資收益 | (2,829) | -3.70% | 4,370 | (2,364) | (5,315) | 8,813 | |
| 其中：對聯營企業和合營企業的投資收益 | (977) | -66.75% | (821) | (3,021) | (8,650) | (3,345) | |
| 營業利潤 | 1,028,298 | 12.65% | 748,406 | 625,987 | 573,931 | 567,609 | |
| 利潤總額 | 1,025,613 | 11.95% | 753,280 | 623,140 | 579,395 | 565,999 | |
| 減：所得稅費用 | 165,106 | 27.88% | 106,887 | 92,190 | 89,072 | 86,563 | |
| 淨利潤 | 860,507 | 9.34% | 646,394 | 530,949 | 490,323 | 479,437 | |
| 減：非控股權益 | 72,314 | 5.82% | 48,153 | 25,262 | 16,584 | 15,840 | |
| 股東淨利潤 | 788,193 | 9.67% | 598,241 | 505,687 | 473,739 | 463,597 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.250 | 9.65% | 0.950 | 0.800 | 0.750 | 0.740 | |
| 每股派息 (元) * | 1.200 | -7.69% | 1.150 | 0.870 | 0.270 | 0.300 | |
| 每股淨資產 (元) * | 6.141 | 0.89% | 6.180 | 6.354 | 6.154 | 6.782 | |
| 審計意見 # | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 21/03/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
